Results 91 to 100 of about 554 (134)

Microaerobic insights into production of polyhydroxyalkanoates containing 3-hydroxyhexanoate via native reverse β-oxidation from glucose in Ralstonia eutropha H16. [PDF]

Microb Cell Fact
Huong KH, Orita I, Fukui T.
europepmc   +1 more source

Enzyme Catalyzed Formation of CoA Adducts of Fluorinated Hexanoic Acid Analogues using a Long-Chain acyl-CoA Synthetase from <i>Gordonia</i> sp. Strain NB4-1Y. [PDF]

Biochemistry
Mothersole RG, Mothersole MK, Goddard HG, Liu J, Van Hamme JD.   +4 more
europepmc   +1 more source

Evaluation of Porous (Poly(lactide-co-glycolide)-co-(ε-caprolactone)) Polyurethane for Use in Orthopedic Scaffolds. [PDF]

Molecules
Savin G, Sastourne-Array O, Caillol S, Bethry A, Assor M, David G, Nottelet B.   +6 more
europepmc   +1 more source

The effects of two short-chain perfluoroalkyl carboxylic acids (PFCAs) on northern leopard frog (Rana pipiens) tadpole development. [PDF]

Ecotoxicology
Rohonczy J, Robinson SA, Forbes MR, De Silva AO, Brinovcar C, Bartlett AJ, Gilroy ÈAM.   +6 more
europepmc   +1 more source

Variability in n-caprylate and n-caproate producing microbiomes in reactors with in-line product extraction. [PDF]

mSystems
Spirito CM, Lucas TN, Patz S, Jeon BS, Werner JJ, Trondsen LH, Guzman JJ, Huson DH, Angenent LT.   +8 more
europepmc   +1 more source

Short-chain fatty acids (SCFA) in infants' plasma and corresponding mother's milk and plasma in relation to subsequent sensitisation and atopic disease. [PDF]

EBioMedicine
Barman M, Gio-Batta M, Andrieux L, Stråvik M, Saalman R, Fristedt R, Rabe H, Sandin A, Wold AE, Sandberg AS.   +9 more
europepmc   +1 more source

Ascorbic Acid 2-Phosphate Releasing Supercritically Foamed Porous Poly-L-Lactide-Co-ε-Caprolactone Scaffold Enhances the Collagen Production of Human Vaginal Stromal Cells: A New Approach for Vaginal Tissue Engineering. [PDF]

Tissue Eng Regen Med
Sartoneva R, Paakinaho K, Hannula M, Kuismanen K, Huhtala H, Hyttinen J, Miettinen S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Accelerated Approval of 17α-Hydroxyprogesterone Caproate

Obstetrics & Gynecology, 2020
Before 2011, 17α-hydroxyprogesterone caproate (17P) was used to prevent recurrent preterm birth in women with singleton pregnancies and was compounded at a low cost (∼$15 per injection). In 2011, the U.S. Food and Drug Administration (FDA) approved a commercial version of 17P (trade name “Makena”) through their Accelerated Approval Program, and the ...
Bethany J, Godlewski, Lily I, Sobolik, Valerie J, King, Curtis S, Harrod   +3 more
openaire   +2 more sources

Influence of gestonorone caproate on rat prostate

Journal of Steroid Biochemistry, 1979
Abstract The mechanism of action of weight reduction of the ventral prostate by gestonorone caproate (GC) in rats was studied. GC was subcutaneously injected (100 mg/week/rat) for 3 weeks in normal rats, castrated rats, castrated rats treated with testosterone propionate (TP, 0.03–0.24 mg/2 days/rat) and hypophysectomized rats treated with human ...
T, Hayashi, H J, Glotz, T, Aono, K, Matsumoto   +3 more
openaire   +2 more sources

Prevention of premature labor by 17α-hydroxyprogesterone caproate

American Journal of Obstetrics and Gynecology, 1985
Eighty pregnant women at high risk of giving birth prematurely were divided randomly into two groups. Treatment with either 17 alpha-hydroxyprogesterone caproate, 250 mg by intramuscular injection once a week, or a placebo was given in a double-blind fashion.
M, Yemini, R, Borenstein, E, Dreazen, Z, Apelman, B M, Mogilner, I, Kessler, M, Lancet   +6 more
openaire   +2 more sources